KHB's Complement C1q Assay Kit Receives Medical Device Registration Certificate

Regulation
โดย CLS·Read original
Summary · why it matters

KHB announced that it recently received a medical device registration certificate from the Shanghai Medical Products Administration for its Complement C1q Assay Kit (latex immunoturbidimetric method), valid until June 29, 2031. The product is used for the in vitro quantitative determination of complement C1q in human serum and plasma. It will enrich the company's product line and have a positive impact on business development, though the specific revenue impact cannot yet be predicted.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews